Mid-Year Report

THE MCMANUS GROUP for ADVAMED

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Comparative effectivness provisions in H.R. 2184, "Enhanced Health Care Value for All Act of 2007" Comparative effectiveness provisions in S. 3, "Medicare Prescription Drug Price Negotiation Act of 2007" H.R. 2900/S. 1082, Medical Device User Fee and Modernization Act reauthorizations H.R. 1494/S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007" Device safety provisions in H.R. 1561, "Enhancing Drug Safety and Innovation Act of 2007"

LobbyistCovered position, as disclosed
JOHN MCMANUS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2900 (110th), H.R. 1494 (110th), S. 1082 (110th), H.R. 1561 (110th), S. 830 (110th), H.R. 2184 (110th), S. 3 (110th)

Medicare/Medicaid MMM

Concerns with implications of proposed reforms in the FY08 hospital inpatient prospective payment system proposed rule S. 631, "Remote Monitoring Access Act of 2007." H.R. 1321, "Medicare Advanced Laboratory Diagnostics Act of 2007" Opposition to payments cuts for imaging services

LobbyistCovered position, as disclosed
JOHN MCMANUS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1321 (110th), S. 631 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.